/ /

Jolie Higazi
Jolie is the Content Specialist for Ophthalmology Times. She can be reached at [email protected]
Top 10 U.S. eye-healthy cities
Top 10 U.S. eye-healthy cities
Check out the latest results from the 2016 VSP Vision Care Eye Health Index!
Stressing the need for child vision screenings
Stressing the need for child vision screenings
As parents and educators around the country are preparing this August for “Back to School” season, it is also Child’s Eye Health and Safety Month, serving as a reminder for parents, educators, and eye-care providers of the importance of vision screening for children. Plus, a new device may help specialists properly diagnose viral or bacteria pink eye in their pediatric patients.
Why Trump and Clinton will be terrible patients
Why Trump and Clinton will be terrible patients
Learn why presidential candidates Donald Trump and Hillary Clinton would both be difficult eye patients.
Microstent approval makes big news in glaucoma world
Microstent approval makes big news in glaucoma world
Clinicians will soon have another treatment option for their patients with non-severe primary open-angle glaucoma (POAG). A micro invasive glaucoma surgical (MIGS) device (CyPass Micro-Stent, Alcon) has been approved by the FDA for use in patients with mild-moderate PAOG in conjunction with cataract surgery.
What books are your fellow ophthalmologists reading?
What books are your fellow ophthalmologists reading?
Looking for summer reading suggestions? Find out what books your colleagues are reading!
Techie-turned ophthalmologist tinkers through fellowship
Sabin Dang, MD, didn’t have as clear cut of a journey to the ophthalmic world as many would expect. While today he spends his working hours improving visual outcomes of patients at Ophthalmic Consultants of Boston, a few years ago you would have found him creating coding software in his IT consulting company to help businesses grow.
Ceeable aims to be the next gold standard in visual fields
Ceeable aims to be the next gold standard in visual fields
Ceeable, a web-based, mobile digital technology designed to detect early-stage eye diseases—an innovation that can help shape 21st century medicine—was awarded third place in the American Medical Association’s inaugural Healthier Nation Innovation Challenge.
Santen to acquire InnFocus, developer of glaucoma drainage implant
Santen Pharmaceutical will soon acquire InnFocus, developer of a glaucoma implant device (InnFocus Microshunt), for $225 million, according to a definitive agreement from the two companies.
FDA approves one-of-a-kind IOL with extended range of vision
FDA approves one-of-a-kind IOL with extended range of vision
It has been a history-making week for the ophthalmic world, and the FDA approval of the first IOL with extended range of vision (Tecnis Symfony IOL, Abbott) has only added one more reason for celebration.
Shire's FDA-approved drug ends dry eye treatment drought
Shire's FDA-approved drug ends dry eye treatment drought
Ophthalmologists have been waiting more than a decade for a new treatment option for their dry eye patients—and the anticipation is finally over. Lifitegrast ophthalmic solution 5% (Xiidra, Shire Ophthalmics) is a twice-daily eye drop solution and is the only FDA-approved drug indicated to treat the signs and symptoms of dry eye disease, according to the company.

Poll

View Results